Background: Recurrent bleedings of cavernous malformations are quite frequent and frightful: survival is especially at risk in patients with brainstem cavernous malformations who cannot benefit from neurosurgical treatments. Nevertheless, pragmatic recommendations to prevent recurrent bleedings are still lacking, raising some questions on the daily clinical management of the above patients. Methods: This study reports the case of a 59 year-old woman presenting with past recurrent bleedings from a brainstem cavernous malformation and with indication to start an anti-thrombotic treatment as a consequence of a developing coronary heart disease. Surprisingly, any suggestion about the usage of otherwise indicated anti-platelet treatment and anti-coagulation in patients with cavernous malformations was found in the literature. Results: The authors faced a therapeutical dilemma with this patient, whose survival would be really at risk because of a 'time bomb in her brainstem'. Conclusions: This experience confirms the lack of clear pragmatic recommendations in the clinical management of these patients, whose treatment still represents a medical challenge.

In uno omnia. anti-thrombotic agents in challenging comorbidities / Pistoia, F; Ferri, C; Desideri, G; Rosano, G; Sarà, M. - In: BRAIN INJURY. - ISSN 0269-9052. - 24:5(2010), pp. 792-796. [10.3109/02699051003709573]

In uno omnia. anti-thrombotic agents in challenging comorbidities

FERRI C;DESIDERI G;
2010

Abstract

Background: Recurrent bleedings of cavernous malformations are quite frequent and frightful: survival is especially at risk in patients with brainstem cavernous malformations who cannot benefit from neurosurgical treatments. Nevertheless, pragmatic recommendations to prevent recurrent bleedings are still lacking, raising some questions on the daily clinical management of the above patients. Methods: This study reports the case of a 59 year-old woman presenting with past recurrent bleedings from a brainstem cavernous malformation and with indication to start an anti-thrombotic treatment as a consequence of a developing coronary heart disease. Surprisingly, any suggestion about the usage of otherwise indicated anti-platelet treatment and anti-coagulation in patients with cavernous malformations was found in the literature. Results: The authors faced a therapeutical dilemma with this patient, whose survival would be really at risk because of a 'time bomb in her brainstem'. Conclusions: This experience confirms the lack of clear pragmatic recommendations in the clinical management of these patients, whose treatment still represents a medical challenge.
2010
cavernous malformation; brainstem haemorrhage; comorbidities; anti-thrombotic treatment
01 Pubblicazione su rivista::01a Articolo in rivista
In uno omnia. anti-thrombotic agents in challenging comorbidities / Pistoia, F; Ferri, C; Desideri, G; Rosano, G; Sarà, M. - In: BRAIN INJURY. - ISSN 0269-9052. - 24:5(2010), pp. 792-796. [10.3109/02699051003709573]
File allegati a questo prodotto
File Dimensione Formato  
Pistoia_In-Uno-Omnia_2010.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 283.07 kB
Formato Adobe PDF
283.07 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1705295
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact